Glomerulonephritis | Current Treatment | US | 2016

Glomerulonephritis (GN) is a condition involving inflammation of the glomerulus, which plays an important role in the filtration of blood into the kidney. If the glomerulus becomes inflamed and damaged, there can be a decline in kidney function leading to chronic kidney disease (CKD). This content provides a deep dive into the dynamics of the GN market, examining the management of GN patients from the perspective of nephrologists. We focus on how GN disorders such as immunoglobulin A (IgA) nephropathy, focal segmental glomerulosclerosis (FSGS), lupus nephritis, and idiopathic membranous glomerulonephritis (IMGN) are being treated in the United States today and on the factors behind those treatment decisions.

Login to access report

launch Related Market Assessment Reports